IL2RA and graft versus host disease: Another study examined MSCs for treating GvHD in 10 patients and showed that mean plasma levels of interleukin 2 receptor alpha (IL-2Rα) and TNFR1 in acute GvHD patients before MSC infusion were high in responders and persistently decreased after MSC treatment [140].